Related Experiment Video

Updated: Aug 20, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

HELLP syndrome: the state of the art

Jason K Baxter1, Louis Weinstein

  • 1Department of Obstetrics and Gynecology, Fellow, Division of Maternal-Fetal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Jason.Baxter@jefferson.edu

Obstetrical & Gynecological Survey
|December 2, 2004
PubMed

Insights

HELLP syndrome, a severe variant of preeclampsia, uniquely affects humans and progresses until delivery, which is its only treatment. Understanding its history and management is crucial for obstetric care.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine

Background:

  • Preeclampsia/eclampsia is a long-recognized obstetric complication.
  • HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) is a severe variant, known for 50 years.
  • Key characteristics include its human-specific nature, progressive course, and that delivery is the sole effective therapy.

Purpose of the Study:

  • To review the history and pathophysiology of HELLP syndrome.
  • To describe the clinical presentation and differential diagnosis of HELLP syndrome.
  • To outline current management options for HELLP syndrome.

Main Methods:

  • Literature review and synthesis of existing data on HELLP syndrome.
  • Analysis of historical observations and clinical findings.
  • Discussion of therapeutic strategies, emphasizing delivery.

Main Results:

  • HELLP syndrome is a distinct, progressive condition unique to humans.
  • Clinical presentation varies, requiring careful differential diagnosis.
  • Delivery remains the definitive treatment, though supportive care is essential.

Conclusions:

  • HELLP syndrome necessitates a thorough understanding of its unique pathophysiology and clinical course.
  • Accurate diagnosis and timely intervention, primarily delivery, are critical for maternal outcomes.
  • Continued research is needed to further elucidate HELLP syndrome mechanisms and optimize management.
Abstract

More Related Videos

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.